| Mrs Maghan Kensi Bryant, MS, CCC-SLP | |
|
215 Dunbar Cave Rd Ste A, Clarksville, TN 37043-8850 | |
| (931) 542-2739 | |
| Not Available |
| Full Name | Mrs Maghan Kensi Bryant |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 215 Dunbar Cave Rd Ste A, Clarksville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053700997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLPLPA00211730 (Kentucky) | Secondary |
| 235Z00000X | Speech-language Pathologist | 5052 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Maghan Kensi Bryant, MS, CCC-SLP 325 E Broadway, Mayfield, KY 42066-2405 Ph: (270) 625-3463 | Mrs Maghan Kensi Bryant, MS, CCC-SLP 215 Dunbar Cave Rd Ste A, Clarksville, TN 37043-8850 Ph: (931) 542-2739 |
News Archive
Furthermore, it will also be used in physiotherapy in hospitals to prevent the secondary effects associated with the loss of mobility in this illness. The technology, which has been patented and licensed jointly by CSIC and its technology-based business unit, Marsi Bionics, is currently in the preclinical phase.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Esophageal Squamous Cell Carcinoma (ESCC), the major histological form of esophageal cancer, is the leading cause of cancer death worldwide. Scientists from the National University of Singapore (NUS) have discovered a biomarker, called adenosine deaminase acting on RNA-1 (ADAR1), which has the potential to improve the diagnosis, prognosis and treatment of this disease.
Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 are associated with a unique susceptibility to the Epstein-Barr virus, which may lead to fatal infectious mononucleosis.
Alzheimer Europe today launched two new publications: "Intercultural dementia care for health and social care providers: a guide" and "Policy briefing on intercultural care and support for people with dementia and their informal carers/supporters".
› Verified 6 days ago
Mrs. Amber Powell, M.A. SLP-CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1621 Autumn Dr, Clarksville, TN 37042 Phone: 931-980-9877 | |
Megan Leigh Mcgrath Durling, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 461 Pond Apple Rd, Clarksville, TN 37043 Phone: 931-920-4333 Fax: 931-920-4346 | |
Susan Johnson Lingg, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 851 Professional Park Dr, Clarksville, TN 37040 Phone: 931-542-2168 Fax: 931-542-2206 | |
Holly Marie Niles, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 Hatcher Ln, Clarksville, TN 37043 Phone: 931-542-2168 Fax: 931-542-2206 | |
Ashley Elizabeth Rust, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 Hatcher Ln, Clarksville, TN 37043 Phone: 931-542-2168 | |
Michael Bush, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 621 Gracey Ave, Clarksville, TN 37040 Phone: 423-622-1551 Fax: 877-856-7133 | |
Rachel Smith, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 621 Gracey Ave, Clarksville, TN 37040 Phone: 423-622-1551 Fax: 877-856-7133 |